{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:37:58Z","timestamp":1794685078721,"version":"4.9.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2413900"],"award-info":[{"award-number":["2023YFC2413900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2021206293"],"award-info":[{"award-number":["H2021206293"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hebei Clinical Research Center for Radiation Oncology","award":["2057702D"],"award-info":[{"award-number":["2057702D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02668-x","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:19:28Z","timestamp":1749100768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Radiation-induced cardiac substructure damage and dose constraints: a review"],"prefix":"10.1186","volume":"20","author":[{"given":"Xinyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-1433","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2668_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189008","volume":"1878","author":"Y Luo","year":"2023","unstructured":"Luo Y, Zeng Z, Liu Y, Liu A. Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy. Biochim Biophys Acta Rev Cancer. 2023;1878: 189008.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2668_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtho.2020.11.002","volume":"16","author":"K Banfill","year":"2021","unstructured":"Banfill K, Giuliani M, Aznar M, Franks K, McWilliam A, Schmitt M, et al. Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions. J Thorac Oncol. 2021;16:216\u201327.","journal-title":"J Thorac Oncol"},{"key":"2668_CR3","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.chest.2021.12.667","volume":"161","author":"BY Liu","year":"2022","unstructured":"Liu BY, Rehmani S, Kale MS, Marshall D, Rosenzweig KE, Kong CY, et al. Risk of cardiovascular toxicity according to tumor laterality among older patients with early stage non-small cell lung cancer treated with radiation therapy. Chest. 2022;161:1666\u201374.","journal-title":"Chest"},{"key":"2668_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA van Nimwegen","year":"2015","unstructured":"van Nimwegen FA, Schaapveld M, Janus CPM, Krol ADG, Petersen EJ, Raemaekers JMM, et al. Cardiovascular disease after hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med. 2015;175:1007\u201317.","journal-title":"JAMA Intern Med"},{"key":"2668_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2022.04.019","volume":"114","author":"AH Zureick","year":"2022","unstructured":"Zureick AH, Grzywacz VP, Almahariq MF, Silverman BR, Vayntraub A, Chen PY, et al. Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2022;114:130\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR6","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1093\/eurheartj\/ehad462","volume":"44","author":"T-Y Lai","year":"2023","unstructured":"Lai T-Y, Hu Y-W, Wang T-H, Chen J-P, Shiau C-Y, Huang P-I, et al. Association of radiation dose to cardiac substructures with major ischaemic events following breast cancer radiotherapy. Eur Heart J. 2023;44:4796\u2013807.","journal-title":"Eur Heart J"},{"key":"2668_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijrobp.2022.08.013","volume":"115","author":"G Cai","year":"2023","unstructured":"Cai G, Li C, Li J, Yang J, Li C, Sun L, et al. Cardiac substructures dosimetric predictors for cardiac toxicity after definitive radiotherapy in esophageal cancer. Int J Radiat Oncol. 2023;115:366\u201381.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang X, Palaskas NL, Yusuf SW, Abe J-I, Lopez-Mattei J, Banchs J, et al. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J Thorac Oncol. 2020;15:1682\u201390.","journal-title":"J Thorac Oncol"},{"key":"2668_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/jnci\/djac120","volume":"114","author":"CH Chapman","year":"2022","unstructured":"Chapman CH, Jagsi R, Griffith KA, Moran JM, Vicini F, Walker E, et al. Mediators of racial disparities in heart dose among whole breast radiotherapy patients. JNCI J Natl Cancer Inst. 2022;114:1646\u201355.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2668_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11912-022-01238-8","volume":"24","author":"E Koutroumpakis","year":"2022","unstructured":"Koutroumpakis E, Deswal A, Yusuf SW, Abe J, Nead KT, Potter AS, et al. Radiation-induced cardiovascular disease: mechanisms, prevention, and treatment. Curr Oncol Rep. 2022;24:543\u201353.","journal-title":"Curr Oncol Rep"},{"key":"2668_CR11","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.prro.2019.09.015","volume":"10","author":"BS Hoppe","year":"2020","unstructured":"Hoppe BS, Bates JE, Mendenhall NP, Morris CG, Louis D, Ho MW, et al. The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era. Pract Radiat Oncol. 2020;10:e147\u201354.","journal-title":"Pract Radiat Oncol"},{"key":"2668_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","volume":"35","author":"K Wang","year":"2017","unstructured":"Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, et al. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: Pooled analysis of dose-escalation trials delivering 70 to 90 gy. J Clin Oncol. 2017;35:1387\u201394.","journal-title":"J Clin Oncol"},{"issue":"24","key":"2668_CR13","first-page":"02332","volume":"S1556\u20130864","author":"A Amini","year":"2024","unstructured":"Amini A, Zaha VG, Hamad E, Woodard PK, Rimner A, Chang JY, et al. American radium society appropriate use criteria on cardiac toxicity prevention and management after thoracic radiotherapy. J Thorac Oncol. 2024;S1556\u20130864(24):02332\u20133.","journal-title":"J Thorac Oncol"},{"key":"2668_CR14","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s11864-022-01012-9","volume":"23","author":"NB Shahed","year":"2022","unstructured":"Shahed NB, Lindsay LP, Gregory V, Ln P, Jd MCB. Radiation-induced cardiovascular toxicities. Curr Treat Options Oncol. 2022;23:1388\u2013404.","journal-title":"Curr Treat Options Oncol"},{"key":"2668_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jaccao.2024.07.007","volume":"6","author":"G Walls","year":"2024","unstructured":"Walls G, McWilliam A. Association of cardiac substructure radiation dose with arrhythmia: time to move away from mean dose. JACC CardioOncology. 2024;6:557\u20139.","journal-title":"JACC CardioOncology"},{"key":"2668_CR16","doi-asserted-by":"crossref","unstructured":"Walls GM, Bergom C, Mitchell JD, Rentschler SL, Hugo GD, Samson PP, et al. Cardiotoxicity following thoracic radiotherapy for lung cancer. Br J Cancer.  2025;132:311\u201325.","DOI":"10.1038\/s41416-024-02888-0"},{"key":"2668_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.07.1802","volume":"108","author":"G Cai","year":"2020","unstructured":"Cai G, Meng X, Yu J. The predictive value of substructure and whole heart dosimetric variables for cardiac events and overall survival in locally advanced esophageal cancer receiving chemoradiotherapy. Int J Radiat Oncol. 2020;108: e588.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR18","doi-asserted-by":"crossref","unstructured":"Cai G, Yu J, Meng X. Cardiotoxicity after chemoradiation for locally advanced esophageal cancer: Contributions of substructure and whole heart dose-volume parameters to risk prediction. J Clin Oncol. 2020;38:e16576\u2013e16576.","DOI":"10.1200\/JCO.2020.38.15_suppl.e16576"},{"key":"2668_CR19","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/j.ijrobp.2021.07.236","volume":"111","author":"G Cai","year":"2021","unstructured":"Cai G, Yu J, Meng X. Dosimetric predictors of cardiac events after concurrent chemoradiotherapy for locally advanced esophageal cancer. Int J Radiat Oncol. 2021;111:S102.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijrobp.2023.08.011","volume":"118","author":"ED Miller","year":"2024","unstructured":"Miller ED, Wu T, McKinley G, Slivnick J, Guha A, Mo X, et al. Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy. Int J Radiat Oncol Biol Phys. 2024;118:124\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13014-024-02560-0","volume":"19","author":"V Nguyen","year":"2024","unstructured":"Nguyen V, Metges J-P, Morjani M, Pourreau P-G, Dhamelincourt E, Queneherv\u00e9 L, et al. Dose to cardiac substructures and cardiovascular events in esophageal cancer patients treated with definitive radiotherapy. Radiat Oncol Lond Engl. 2024;19:175.","journal-title":"Radiat Oncol Lond Engl"},{"key":"2668_CR22","doi-asserted-by":"publisher","first-page":"110544","DOI":"10.1016\/j.radonc.2024.110544","volume":"201","author":"F Tohidinezhad","year":"2024","unstructured":"Tohidinezhad F, N\u00fcrnberg L, Vaassen F, Ma Ter Bekke R, Jwl Aerts H, El Hendriks L, et al. Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy. Radiother Oncol. 2024;201:110544.","journal-title":"Radiother Oncol"},{"key":"2668_CR23","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijrobp.2022.07.440","volume":"114","author":"KM Atkins","year":"2022","unstructured":"Atkins KM, Nikolova A, Guthier CV, Bitterman DS, Kozono DE, Nohria A, et al. Association of cardiac sub-structure radiation dose with bradyarrhythmias and tachyarrhythmias after lung cancer radiotherapy. Int J Radiat Oncol. 2022;114:S58\u20139.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.07.1563","volume":"114","author":"N Yegya-Raman","year":"2022","unstructured":"Yegya-Raman N, Kegelman TP, Lee SH, Kim KN, Natarajan J, Kallan MJ, et al. Association between cardiovascular substructure dose and death without progression after chemoradiation for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2022;114: e399.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.892882","volume":"12","author":"MY Errahmani","year":"2022","unstructured":"Errahmani MY, Locquet M, Spoor D, Jimenez G, Camilleri J, Bernier M-O, et al. Association between cardiac radiation exposure and the risk of arrhythmia in breast cancer patients treated with radiotherapy: a case\u2013control study. Front Oncol. 2022;12: 892882.","journal-title":"Front Oncol"},{"key":"2668_CR26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/cancers14061391","volume":"14","author":"M Farrugia","year":"2022","unstructured":"Farrugia M, Yu H, Ma SJ, Iovoli AJ, Pokharel S, Sharma UC, et al. Right atrial dose is associated with worse outcome in patients undergoing definitive stereotactic body radiation therapy for central lung tumors. Cancers. 2022;14:1391.","journal-title":"Cancers"},{"key":"2668_CR27","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1038\/s41598-023-37546-7","volume":"13","author":"SY Wang","year":"2023","unstructured":"Wang SY, Lin KH, Wu YW, Yu CW, Yang SY, Shueng PW, et al. Evaluation of the cardiac subvolume dose and myocardial perfusion in left breast cancer patients with postoperative radiotherapy: a prospective study. Sci Rep. 2023;13:10578.","journal-title":"Sci Rep"},{"key":"2668_CR28","first-page":"14","volume":"126","author":"A Arslan","year":"2021","unstructured":"Arslan A, Aktas E, Sengul B, Tekin B. Dosimetric evaluation of left ventricle and left anterior descending artery in left breast radiotherapy. Breast Radiol. 2021;126:14\u201321.","journal-title":"Breast Radiol"},{"key":"2668_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","volume":"125","author":"K Wang","year":"2017","unstructured":"Wang K, Pearlstein KA, Patchett ND, Deal AM, Mavroidis P, Jensen BC, et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non-small-cell lung cancer. Radiother Oncol. 2017;125:293\u2013300.","journal-title":"Radiother Oncol"},{"key":"2668_CR30","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.jtho.2018.05.028","volume":"13","author":"N Yegya-Raman","year":"2018","unstructured":"Yegya-Raman N, Wang K, Kim S, Reyhan M, Deek MP, Sayan M, et al. Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC. J Thorac Oncol. 2018;13:1508\u201318.","journal-title":"J Thorac Oncol"},{"key":"2668_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.radonc.2020.09.050","volume":"152","author":"BS Jang","year":"2020","unstructured":"Jang BS, Cha MJ, Kim HJ, Oh S, Wu HG, Kim E, et al. Heart substructural dosimetric parameters and risk of cardiac events after definitive chemoradiotherapy for stage III non-small cell lung cancer. Radiother Oncol. 2020;152:126\u201332.","journal-title":"Radiother Oncol"},{"key":"2668_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","volume":"7","author":"KM Atkins","year":"2021","unstructured":"Atkins KM, Chaunzwa TL, Lamba N, Bitterman DS, Rawal B, Bredfeldt J, et al. Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer. JAMA Oncol. 2021;7:206\u201319.","journal-title":"JAMA Oncol"},{"key":"2668_CR33","doi-asserted-by":"crossref","unstructured":"Yegya-Raman N, Kegelman TP, Ho Lee S, Kallan MJ, Kim KN, Natarajan J, et al. Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer. Clin Transl Radiat Oncol. 2023;39:100581.","DOI":"10.1016\/j.ctro.2023.100581"},{"key":"2668_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ejhf.1376","volume":"21","author":"I Mansouri","year":"2019","unstructured":"Mansouri I, Allodji RS, Hill C, El-Fayech C, Pein F, Diallo S, et al. The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer. Eur J Heart Fail. 2019;21:509\u201318.","journal-title":"Eur J Heart Fail"},{"key":"2668_CR35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ijrobp.2021.03.004","volume":"110","author":"VAB van den Bogaard","year":"2021","unstructured":"van den Bogaard VAB, Spoor DS, van der Schaaf A, van Dijk LV, Schuit E, Sijtsema NM, et al. The importance of radiation dose to the atherosclerotic plaque in the left anterior descending coronary artery for radiation-induced cardiac toxicity of breast cancer patients? Int J Radiat Oncol Biol Phys. 2021;110:1350\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.radonc.2018.09.021","volume":"132","author":"S Tang","year":"2019","unstructured":"Tang S, Otton J, Holloway L, Delaney GP, Liney G, George A, et al. Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy. Radiother Oncol. 2019;132:257\u201365.","journal-title":"Radiother Oncol"},{"key":"2668_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijrobp.2023.10.037","volume":"119","author":"A Omidi","year":"2023","unstructured":"Omidi A, Weiss E, Rosu-Bubulac M, Thomas G, Wilson JS. Quantitative analysis of radiation therapy-induced cardiac and aortic sequelae in patients with lung cancer via magnetic resonance imaging: a pilot study. Int J Radiat Oncol Biol Phys. 2023;119:281\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cllc.2019.10.010","volume":"21","author":"ST Chan","year":"2020","unstructured":"Chan ST, Ruan D, Shaverdian N, Raghavan G, Cao M, Lee P. Effect of radiation doses to the heart on survival for stereotactic ablative radiotherapy for early-stage non-small-cell lung cancer: an artificial neural network approach. Clin Lung Cancer. 2020;21:136-144.e1.","journal-title":"Clin Lung Cancer"},{"key":"2668_CR39","unstructured":"Chen S, Wang S, Tang Y, Zhang J, Tan S, Huan F, et al. Prospective study of subclinical cardiac injury after breast conserving surgery with large segment radiotherapy. Chin J Cancer.  2020;42:456\u201362."},{"key":"2668_CR40","volume-title":"Anatomy, thorax, heart left anterior descending (LAD) artery","author":"I Rehman","year":"2024","unstructured":"Rehman I, Kerndt CC, Rehman A. Anatomy, thorax, heart left anterior descending (LAD) artery. Treasure Island: StatPearls; 2024."},{"key":"2668_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.ijrobp.2022.11.033","volume":"115","author":"E McKenzie","year":"2023","unstructured":"McKenzie E, Zhang S, Zakariaee R, Guthier CV, Hakimian B, Mirhadi A, et al. Left anterior descending coronary artery radiation dose association with all-cause mortality in NRG oncology trial RTOG 0617. Int J Radiat Oncol Biol Phys. 2023;115:1138\u201343.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2022.02.010","volume":"169","author":"MC Tjong","year":"2022","unstructured":"Tjong MC, Bitterman DS, Brantley K, Nohria A, Hoffmann U, Atkins KM, et al. Major adverse cardiac event risk prediction model incorporating baseline cardiac disease, hypertension, and logarithmic left anterior descending coronary artery radiation dose in lung cancer (CHyLL). Radiother Oncol. 2022;169:105\u201313.","journal-title":"Radiother Oncol"},{"key":"2668_CR43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaccao.2023.08.007","volume":"5","author":"HJ No","year":"2023","unstructured":"No HJ, Guo FB, Park NJI, Kastelowitz N, Rhee JW, Clark DE, et al. Predicting adverse cardiac events after radiotherapy for locally advanced non\u2013small cell lung cancer. JACC CardioOncology. 2023;5:775\u201387.","journal-title":"JACC CardioOncology"},{"key":"2668_CR44","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ijrobp.2021.03.005","volume":"110","author":"KM Atkins","year":"2021","unstructured":"Atkins KM, Bitterman DS, Chaunzwa TL, Kozono DE, Baldini EH, Aerts HJWL, et al. Mean heart dose is an inadequate surrogate for left anterior descending coronary artery dose and the risk of major adverse cardiac events in lung cancer radiation therapy. Int J Radiat Oncol. 2021;110:1473\u20139.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110005","volume":"190","author":"N Yegya-Raman","year":"2024","unstructured":"Yegya-Raman N, Ho Lee S, Friedes C, Wang X, Iocolano M, Kegelman TP, et al. Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2024;190: 110005.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"2668_CR46","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/cancers14051304","volume":"14","author":"X Wang","year":"2022","unstructured":"Wang X, Palaskas NL, Hobbs BP, Abe J-I, Nead KT, Yusuf SW, et al. The impact of radiation dose to heart substructures on major coronary events and patient survival after chemoradiation therapy for esophageal cancer. Cancers. 2022;14:1304.","journal-title":"Cancers"},{"key":"2668_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100969","volume":"48","author":"Z Jin","year":"2024","unstructured":"Jin Z, Sun X, Zhou C, Yang H, Zhou S. Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy. Neoplasia. 2024;48: 100969.","journal-title":"Neoplasia"},{"key":"2668_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00066-018-1299-x","volume":"194","author":"A Munshi","year":"2018","unstructured":"Munshi A, Khataniar N, Sarkar B, Bera ML, Mohanti BK. Spatial orientation of coronary arteries and its implication for breast and thoracic radiotherapy-proposing \u201ccoronary strip\u201d as a new organ at risk. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2018;194:711\u20138.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"2668_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","volume":"30","author":"G Nilsson","year":"2012","unstructured":"Nilsson G, Holmberg L, Garmo H, Duvernoy O, Sj\u00f6gren I, Lagerqvist B, et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012;30:380\u20136.","journal-title":"J Clin Oncol"},{"key":"2668_CR50","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1200\/JCO.2006.08.6595","volume":"25","author":"CR Correa","year":"2007","unstructured":"Correa CR, Litt HI, Hwang W-T, Ferrari VA, Solin LJ, Harris EE. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25:3031\u20137.","journal-title":"J Clin Oncol"},{"key":"2668_CR51","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317\u201327.","journal-title":"N Engl J Med"},{"key":"2668_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307\u201316.","journal-title":"N Engl J Med"},{"key":"2668_CR53","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","volume":"98","author":"E Hahn","year":"2017","unstructured":"Hahn E, Jiang H, Ng A, Bashir S, Ahmed S, Tsang R, et al. Late cardiac toxicity after mediastinal radiation therapy for hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction. Int J Radiat Oncol. 2017;98:1116\u201323.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaccao.2024.07.005","volume":"6","author":"KM Atkins","year":"2024","unstructured":"Atkins KM, Zhang SC, Kehayias C, Guthier C, He J, Gasho JO, et al. Cardiac substructure radiation dose and associations with tachyarrhythmia and bradyarrhythmia after lung cancer radiotherapy. JACC CardioOncology. 2024;6:544\u201356.","journal-title":"JACC CardioOncology"},{"key":"2668_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.109453","volume":"180","author":"ML Holm Milo","year":"2023","unstructured":"Holm Milo ML, Slot M\u00f8ller D, Bisballe Nyeng T, Hoffmann L, Dahl Nissen H, Jensen I, et al. Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: a DBCG study based on modern radiation therapy techniques. Radiother Oncol. 2023;180: 109453.","journal-title":"Radiother Oncol"},{"key":"2668_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2016.01.045","volume":"58","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Asaithamby A. Ionizing radiation and heart risks. Semin Cell Dev Biol. 2016;58:14\u201325.","journal-title":"Semin Cell Dev Biol"},{"key":"2668_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","volume":"8","author":"BJJM Brundel","year":"2022","unstructured":"Brundel BJJM, Ai X, Hills MT, Kuipers MF, Lip GYH, De Groot NMS. Atrial fibrillation. Nat Rev Dis Prim. 2022;8:21.","journal-title":"Nat Rev Dis Prim"},{"key":"2668_CR58","doi-asserted-by":"publisher","first-page":"110085","DOI":"10.1016\/j.radonc.2024.110085","volume":"192","author":"GM Walls","year":"2024","unstructured":"Walls GM, McCann C, O\u2019Connor J, O\u2019Sullivan A, Johnston D, McAleese J, et al. Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis. Radiother Oncol. 2024;192:110085.","journal-title":"Radiother Oncol"},{"key":"2668_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijrobp.2014.02.011","volume":"89","author":"C-B Han","year":"2014","unstructured":"Han C-B, Wang W-L, Quint L, Xue J-X, Matuszak M, Ten Haken R, et al. Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancer. Int J Radiat Oncol. 2014;89:313\u201321.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13014-017-0772-5","volume":"12","author":"JT Ma","year":"2017","unstructured":"Ma JT, Sun L, Sun X, Xiong ZC, Liu Y, Zhang SL, et al. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy? Radiat Oncol. 2017;12:34.","journal-title":"Radiat Oncol"},{"key":"2668_CR61","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","volume":"123","author":"B Stam","year":"2017","unstructured":"Stam B, Peulen H, Guckenberger M, Mantel F, Hope A, Werner-Wasik M, et al. Dose to heart substructures is associated with non-cancer death after SBRT in stage I\u2013II NSCLC patients. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;123:370\u20135.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"2668_CR62","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/0284186X.2023.2177976","volume":"62","author":"P Loap","year":"2023","unstructured":"Loap P, Vu-Bezin J, Monceau V, Jacob S, Fourquet A, Kirova Y. Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT). Acta Oncol. 2023;62:150\u20138.","journal-title":"Acta Oncol"},{"key":"2668_CR63","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jamaoncol.2022.4202","volume":"8","author":"KH Kim","year":"2022","unstructured":"Kim KH, Oh J, Yang G, Lee J, Kim J, Gwak S-Y, et al. Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer. JAMA Oncol. 2022;8:1624\u201334.","journal-title":"JAMA Oncol"},{"key":"2668_CR64","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.prro.2023.09.005","volume":"14","author":"AJ Iovoli","year":"2024","unstructured":"Iovoli AJ, Yu H, Advani PG, Turecki L, Malhotra HK, Malik NK, et al. Sinoatrial node dose is associated with worse survival in patients undergoing definitive stereotactic body radiation therapy for central lung cancers. Pr Radiat Oncol. 2024;14:e40\u20137.","journal-title":"Pr Radiat Oncol"},{"key":"2668_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijrobp.2017.04.026","volume":"99","author":"S Vivekanandan","year":"2017","unstructured":"Vivekanandan S, Landau DB, Counsell N, Warren DR, Khwanda A, Rosen SD, et al. The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;99:51\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR66","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1016\/j.prro.2021.02.002","volume":"11","author":"P Loap","year":"2021","unstructured":"Loap P, Servois V, Dhonneur G, Kirov K, Fourquet A, Kirova Y. A radiation therapy contouring atlas for cardiac conduction node delineation. Pract Radiat Oncol. 2021;11:e434\u20137.","journal-title":"Pract Radiat Oncol"},{"key":"2668_CR67","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/mp.16846","volume":"51","author":"X Jin","year":"2024","unstructured":"Jin X, Hao Y, Hilliard J, Zhang Z, Thomas MA, Li H, et al. A quality assurance framework for routine monitoring of deep learning cardiac substructure computed tomography segmentation models in radiotherapy. Med Phys. 2024;51:2741\u201358.","journal-title":"Med Phys"},{"key":"2668_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110061","volume":"191","author":"X Chen","year":"2024","unstructured":"Chen X, Mumme RP, Corrigan KL, Mukai-Sasaki Y, Koutroumpakis E, Palaskas NL, et al. Deep learning-based automatic segmentation of cardiac substructures for lung cancers. Radiother Oncol. 2024;191: 110061.","journal-title":"Radiother Oncol"},{"key":"2668_CR69","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ijrobp.2024.05.013","volume":"120","author":"N Summerfield","year":"2024","unstructured":"Summerfield N, Morris E, Banerjee S, He Q, Ghanem AI, Zhu S, et al. Enhancing precision in cardiac segmentation for magnetic resonance-guided radiation therapy through deep learning. Int J Radiat Oncol Biol Phys. 2024;120:904\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108853","volume":"179","author":"A-W Zwijnen","year":"2024","unstructured":"Zwijnen A-W, Watzema L, Ridwan Y, van Der Pluijm I, Smal I, Essers J. Self-adaptive deep learning-based segmentation for universal and functional clinical and preclinical CT image analysis. Comput Biol Med. 2024;179: 108853.","journal-title":"Comput Biol Med"},{"key":"2668_CR71","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bjc.6605191","volume":"101","author":"T Wethal","year":"2009","unstructured":"Wethal T, Lund M-B, Edvardsen T, Foss\u00e5 SD, Pripp AH, Holte H, et al. Valvular dysfunction and left ventricular changes in Hodgkin\u2019s lymphoma survivors. A longitudinal study. Br J Cancer. 2009;101:575\u201381.","journal-title":"Br J Cancer"},{"key":"2668_CR72","doi-asserted-by":"publisher","first-page":"djv008","DOI":"10.1093\/jnci\/djv008","volume":"107","author":"DJ Cutter","year":"2015","unstructured":"Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, Van Nimwegen FA, Krol ADG, et al. Risk for valvular heart disease after treatment for Hodgkin lymphoma. JNCI J Natl Cancer Inst. 2015;107:djv008.","journal-title":"JNCI J Natl Cancer Inst."},{"key":"2668_CR73","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2021.10.016","volume":"165","author":"S Vivekanandan","year":"2021","unstructured":"Vivekanandan S, Fenwick JD, Counsell N, Panakis N, Stuart R, Higgins GS, et al. Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: validation and new discoveries in an independent dataset. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2021;165:119\u201325.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"2668_CR74","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00006534-198507000-00027","volume":"76","author":"RM Goldwyn","year":"1985","unstructured":"Goldwyn RM. Gray\u2019s anatomy. Plast Reconstr Surg. 1985;76:147\u20138.","journal-title":"Plast Reconstr Surg"},{"key":"2668_CR75","doi-asserted-by":"publisher","first-page":"S497","DOI":"10.1016\/S0167-8140(21)06989-9","volume":"161","author":"K Banfill","year":"2021","unstructured":"Banfill K, Wood J, Charlwood F, Lines D, Rompokos V, Hiley C, et al. Cardiac substructure avoidance in lung cancer using photon vs proton radiotherapy: a planning study. Radiother Oncol. 2021;161:S497\u20138.","journal-title":"Radiother Oncol"},{"issue":"85","key":"2668_CR76","first-page":"106","volume":"2017","author":"A McWilliam","year":"1990","unstructured":"McWilliam A, Kennedy J, Hodgson C, Osorio EV, Faivre-Finn C, Van Herk M. Radiation dose to heart base linked with poorer survival in lung cancer patients. Eur J Cancer Oxf Engl. 1990;2017(85):106\u201313.","journal-title":"Eur J Cancer Oxf Engl"},{"key":"2668_CR77","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ijrobp.2020.06.031","volume":"108","author":"A McWilliam","year":"2020","unstructured":"McWilliam A, Khalifa J, Vasquez Osorio E, Banfill K, Abravan A, Faivre-Finn C, et al. Novel methodology to investigate the effect of radiation dose to heart substructures on overall survival. Int J Radiat Oncol Biol Phys. 2020;108:1073\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR78","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.radonc.2020.04.008","volume":"152","author":"C Johnson-Hart","year":"2020","unstructured":"Johnson-Hart C, Price G, McWilliam A, Green A, Faivre-Finn C, van Herk M. Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy. Radiother Oncol. 2020;152:177\u201382.","journal-title":"Radiother Oncol"},{"key":"2668_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jtho.2022.09.004","volume":"18","author":"M Craddock","year":"2023","unstructured":"Craddock M, Nestle U, Koenig J, Schimek-Jasch T, Kremp S, Lenz S, et al. Cardiac function modifies the impact of heart base dose on survival: a voxel-wise analysis of patients with lung cancer from the PET-plan trial. J Thorac Oncol. 2023;18:57\u201366.","journal-title":"J Thorac Oncol"},{"key":"2668_CR80","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clon.2023.11.029","volume":"36","author":"GM Walls","year":"2024","unstructured":"Walls GM, O\u2019Connor J, Harbinson M, Duane F, McCann C, McKavanagh P, et al. The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: results from the NI-HEART study. Clin Oncol R Coll Radiol. 2024;36:119\u201327.","journal-title":"Clin Oncol R Coll Radiol"},{"key":"2668_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110654","volume":"202","author":"T Marchant","year":"2024","unstructured":"Marchant T, Wood J, Banfill K, McWilliam A, Price G, Faivre-Finn C. Dosimetric impact of sparing base of heart on organ at risk doses during lung radiotherapy. Radiother Oncol. 2024;202: 110654.","journal-title":"Radiother Oncol"},{"key":"2668_CR82","first-page":"e342","volume":"117","author":"A Tam","year":"2023","unstructured":"Tam A, Wong C, Liu JR, Eustace NJ, Ketcherside T, Liu A, et al. Dosimetric evaluation of cardiac substructures in irradiation of esophagus. Int J Radiat Oncol Biol Phys. 2023;117:e342\u20133.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR83","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.radonc.2020.06.015","volume":"150","author":"MLH Milo","year":"2020","unstructured":"Milo MLH, Offersen BV, Bechmann T, Diederichsen ACP, Hansen CR, Holtved E, et al. Delineation of whole heart and substructures in thoracic radiation therapy: national guidelines and contouring atlas by the Danish multidisciplinary cancer groups. Radiother Oncol. 2020;150:121\u20137.","journal-title":"Radiother Oncol"},{"key":"2668_CR84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijrobp.2020.08.051","volume":"109","author":"E Nicolas","year":"2021","unstructured":"Nicolas E, Khalifa N, Laporte C, Bouhroum S, Kirova Y. Safety margins for the delineation of the left anterior descending artery in patients treated for breast cancer. Int J Radiat Oncol. 2021;109:267\u201372.","journal-title":"Int J Radiat Oncol"},{"key":"2668_CR85","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","volume":"122","author":"F Duane","year":"2017","unstructured":"Duane F, Aznar MC, Bartlett F, Cutter DJ, Darby SC, Jagsi R, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol. 2017;122:416\u201322.","journal-title":"Radiother Oncol"},{"key":"2668_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109680","volume":"184","author":"GM Walls","year":"2023","unstructured":"Walls GM, McCann C, Ball P, Atkins KM, Mak RH, Bedair A, et al. A pulmonary vein atlas for radiotherapy planning. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2023;184: 109680.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"2668_CR87","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.radonc.2021.12.041","volume":"167","author":"J Socha","year":"2022","unstructured":"Socha J, Rygielska A, Uzi\u0119b\u0142o-\u017byczkowska B, Cha\u0142ubi\u0144ska-Fendler J, Jurek A, Maciorowska M, et al. Contouring cardiac substructures on average intensity projection 4D-CT for lung cancer radiotherapy: a proposal of a heart valve contouring atlas. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2022;167:261\u20138.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"2668_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","volume":"79","author":"M Feng","year":"2011","unstructured":"Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79:10\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2668_CR89","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","volume":"122","author":"F Duane","year":"2017","unstructured":"Duane F, Aznar MC, Bartlett F, Cutter DJ, Darby SC, Jagsi R, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;122:416\u201322.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"2668_CR90","unstructured":"National Cancer Center\/National Center for Cancer Quality Control. Guidelines for target mapping and planning design of postoperative radiotherapy for breast cancer. Chinese Journal of Radiation Oncology 2022; And 63\u2013878."},{"key":"2668_CR91","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1016\/j.cllc.2017.08.002","volume":"19","author":"OY Wong","year":"2018","unstructured":"Wong OY, Yau V, Kang J, Glick D, Lindsay P, Le LW, et al. Survival impact of cardiac dose following lung stereotactic body radiotherapy. Clin Lung Cancer. 2018;19:e241\u20136.","journal-title":"Clin Lung Cancer"},{"key":"2668_CR92","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cllc.2019.05.014","volume":"20","author":"JF Borkenhagen","year":"2019","unstructured":"Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM. Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer. Clin Lung Cancer. 2019;20:435\u201341.","journal-title":"Clin Lung Cancer"},{"key":"2668_CR93","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","volume":"3","author":"JD Mitchell","year":"2021","unstructured":"Mitchell JD, Cehic DA, Morgia M, Bergom C, Toohey J, Guerrero PA, et al. Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the international cardio-oncology society. JACC CardioOncology. 2021;3:360\u201380.","journal-title":"JACC CardioOncology"},{"key":"2668_CR94","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35:893\u2013911.","journal-title":"J Clin Oncol"},{"key":"2668_CR95","doi-asserted-by":"crossref","unstructured":"Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2020;31:171\u201390.","DOI":"10.1016\/j.annonc.2019.10.023"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02668-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T06:03:56Z","timestamp":1749103436000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02668-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02668-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}